Patent · US Active

C16 unsaturated FP-selective prostaglandins analogs

USRE43372E1 · kind E1 · reissue

1Cited by
173References
66Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 2009
Grant dateMay 8, 2012
Priority date
Expiry dateJun 5, 2029

Classification

  • Technology area (CPC —)General

Abstract

Compounds having the general structure:which are useful for the treatment of a variety of diseases and conditions, such as bone disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.